Physician profile
Gigi Kroll
NPI 1912951773
$4,905.52
in general payments reported to CMS, 2019-2025
35 companies · $924 in 2025
The $924 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $606 · 2020: $205 · 2021: $685 · 2022: $864 · 2023: $571 · 2024: $1,050 · 2025: $924.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,371 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,370.69 |
| Education | $174.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $989.28 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $366.87 | 2021-2025 | |
| Astellas Pharma US INC | $311.52 | 2024-2025 | Veozah |
| Organon LLC | $238.61 | 2022-2025 | Nexplanon |
| Pfizer INC. | $216.51 | 2022-2024 | |
| Evofem Biosciences, INC. | $212.88 | 2021-2025 | Phexxi, Solosec, Phexx |
| Exact Sciences Corporation | $195.65 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Novo Nordisk INC | $191.75 | 2023-2025 | Wegovy |
| Allergan, INC. | $170.42 | 2019 | |
| Exeltis, USA INC. | $169.69 | 2019-2025 | Slynd |
| Sumitomo Pharma America, INC. | $167.29 | 2023-2024 | Myfembree |
| Biogen, INC. | $151.61 | 2024-2025 | Zurzuvae |
| Baxter Healthcare | $150.86 | 2024-2025 | Perclot |
| Therapeuticsmd, INC. | $148.72 | 2019-2022 | |
| Myovant Sciences INC. | $139.31 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $138.58 | 2021-2025 | Novasure, Fluent Fluid Management System, Myosure Tissue Removal Device |
| Axonics, INC. | $133.04 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $124.64 | 2019-2025 | |
| Avion Pharmaceuticals | $105.53 | 2019-2021 | |
| Lilly USA, LLC | $98.17 | 2025 | Zepbound |
| Revance Therapeutics, INC. | $48.18 | 2025 | Daxxify |
| Millicent US INC | $45.77 | 2025 | Femlyv, Intrarosa, Femring |
| Vertical Pharmaceuticals, LLC | $43.76 | 2019 | |
| Lupin INC. | $41.53 | 2019-2020 | |
| Agile Therapeutics, INC. | $39.06 | 2021 | |
| Ascend Therapeutics US, LLC | $35.68 | 2023-2024 | |
| Amgen INC. | $35.49 | 2024-2025 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $35.00 | 2019-2020 | |
| Currax Pharmaceuticals LLC | $34.09 | 2025 | Contrave |
| Axsome Therapeutics, INC. | $30.86 | 2025 | Symbravo |
| Coopersurgical, INC. | $24.87 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $19.56 | 2019 | |
| Meditrina | $19.46 | 2025 | |
| Duchesnay USA Incorporated | $17.06 | 2019 | |
| Channel Medsystems, INC. | $14.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gigi Kroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.